Blue Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$432K Sell
5,001
-2,616
-34% -$232K ﹤0.01% 524
2026
Q2
$689K Sell
7,617
-3,196
-30% -$268K 0.01% 386
2026
Q1
$866K Sell
10,813
-403
-4% -$33.2K 0.01% 320
2025
Q4
$956K Buy
11,216
+3,661
+48% +$300K 0.01% 295
2025
Q3
$588K Sell
7,555
-19
-0.3% -$1.48K 0.01% 440
2025
Q2
$592K Sell
7,574
-5
-0.1% -$373 0.01% 399
2025
Q1
$549K Sell
7,579
-207
-3% -$14.8K 0.01% 389
2024
Q4
$576K Sell
7,786
-263
-3% -$18.4K 0.01% 342
2024
Q3
$743K Buy
8,049
+2,998
+59% +$218K 0.01% 339
2024
Q2
$483K Buy
5,051
+1,397
+38% +$124K 0.01% 391
2024
Q1
$349K Buy
3,654
+1,697
+87% +$143K ﹤0.01% 351
2023
Q4
$136K Sell
1,957
-8
-0.4% -$557 ﹤0.01% 571
2023
Q3
$186K Buy
1,965
+199
+11% +$16K ﹤0.01% 450
2023
Q2
$146K Sell
1,766
-694
-28% -$60.3K ﹤0.01% 422
2023
Q1
$183K Sell
2,460
-1,293
-34% -$102K ﹤0.01% 573
2022
Q4
$310K Buy
3,753
+1,263
+51% +$97.3K 0.01% 344
2022
Q3
$237K Buy
2,490
+449
+22% +$43.2K ﹤0.01% 319
2022
Q2
$240K Buy
+2,041
New +$211K ﹤0.01% 294

Other funds holding EW

Blue Trust's EW Position: Q3 2026 in Review

Blue Trust reduced its Edwards Lifesciences (EW) stake by 34% in Q3 2026, selling an estimated $232K and leaving 5,001 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #524.

Blue Trust first reported a position in EW in Q2 2022 and has held it in 18 quarters since. The position peaked at $956K in Q4 2025. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Blue Trust held 5,001 shares of Edwards Lifesciences worth $432K as of Q3 2026.
  • Blue Trust sold 2,616 Edwards Lifesciences shares in Q3 2026, an estimated $232K.
  • Edwards Lifesciences made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #524 holding.
  • Blue Trust first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's Edwards Lifesciences position peaked at $956K in Q4 2025.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.